Paper Details

  1. Home
  2. Paper Details

Evaluation of analgesic effect and absorption of buprenorphine after buccal administration in cats with oral disease.

Author: JohnstonAtholl, KoukiMaria, PapadimitriouSerafeim, PelligandLudovic, PypendopBruno H, StathopoulouThaleia-Rengina

Clinical Trial, VeterinaryClinical trials involving animals. They are conducted to evaluate the safety and efficacy of new drugs and treatments and contribute to the advancement of veterinary medicine.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Buprenorphine is a pain reliever that can be given to cats. This study looked at the effectiveness of giving buprenorphine to cats with mouth pain. The study found that buprenorphine was effective in reducing pain and that it was safe for cats to take.
Paper Details　
Original Abstract of the Article :
Objectives The objective of this study was to evaluate the analgesic effect and absorption of buprenorphine after buccal administration in cats with oral disease. Methods Six adult client-owned cats with chronic gingivostomatitis (weighing 5.1 ± 1.1 kg) were recruited for a randomised, prospective, ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/1098612X17727234

データ提供：米国国立医学図書館（NLM）

Buccal Buprenorphine: A New Oasis for Pain Relief in Cats

The vast desert of veterinary medicine is a continuous quest for effective pain management strategies for our furry companions. This study explores the potential of buccal buprenorphine, a pain medication that is administered through the cheek, for treating pain in cats with oral disease. The researchers investigated the analgesic effects and pharmacokinetic properties of buccal buprenorphine in cats with chronic gingivostomatitis, a condition characterized by inflammation of the gums and mouth.

Buccal Buprenorphine: A Convenient and Effective Option for Cats

The study found that buccal buprenorphine provided effective pain relief for cats with chronic gingivostomatitis, with minimal side effects. The researchers also noted that buccal administration provided consistent and predictable drug levels, making it a promising option for pain management. Imagine a camel in the desert facing a painful thorn in its paw. Buccal buprenorphine in this analogy is like a soothing balm, providing relief directly to the source of pain.

A New Approach to Pain Management in Cats

This research provides valuable insights into the potential of buccal buprenorphine as a convenient and effective pain management strategy for cats with oral disease. The findings suggest that this approach could improve patient comfort and enhance the overall treatment experience.

Dr. Camel's Conclusion

The quest for better pain management options for our animal companions is a vital undertaking. This study highlights the potential of buccal buprenorphine as a promising new approach, offering hope for a more comfortable and less stressful treatment journey for cats with oral disease.

Date :
  1. Date Completed 2019-09-09
  2. Date Revised 2019-09-09
Further Info :

Pubmed ID

28895776

DOI: Digital Object Identifier

10.1177/1098612X17727234

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.